Ankylosing Spondylitis: Symptoms, Diagnosis and Treatment
Ankylosing spondylitis is a chronic inflammatory condition within the axial spondyloarthritis group. It mainly affects the sacroiliac joints and spine, causing inflammatory back pain and stiffness. Some people also develop inflammation in the hips, shoulders, heels, eyes, skin or bowel. The course varies, and not everyone develops spinal fusion. If you are researching ankylosing spondylitis treatment in dwarka, it is useful to understand how the condition is assessed, which treatment approaches may be considered and why follow-up is important. Medical care should be based on an individual's symptoms, examination findings, test results, other health conditions and preferences. Information on this page is educational and cannot replace an in-person assessment or an individual treatment plan.
Ankylosing spondylitis is a chronic inflammatory condition within the axial spondyloarthritis group. It mainly affects the sacroiliac joints and spine, causing inflammatory back pain and stiffness. Some people also develop inflammation in the hips, shoulders, heels, eyes, skin or bowel. The course varies, and not everyone develops spinal fusion. The name describes a specific disease pattern, but the way it affects each person can be different. Some people have symptoms limited mainly to one organ system, while others develop features involving several parts of the body. Disease activity may change over time. A clinician considers the pattern, duration and severity of symptoms rather than making a decision from one symptom or laboratory result.
Symptoms associated with ankylosing spondylitis may include gradual-onset lower-back or buttock pain; stiffness after rest or on waking; pain that may improve with movement; waking during the second half of the night because of back discomfort; reduced spinal flexibility; heel pain; fatigue; or episodes of a painful red eye. Symptoms commonly begin before age 45 but can vary.. The presence of one or more of these features does not automatically confirm the condition. Similar symptoms can occur in other illnesses, and the pattern over time is often important.
The causes of ankylosing spondylitis are not always fully understood. Current medical knowledge points to genetic and immune factors. HLA-B27 is associated with the condition, but a positive result does not confirm it and a negative result does not rule it out. Family history may increase susceptibility. The condition is not contagious and is not caused simply by poor posture or ordinary muscle strain. Risk factors are not the same as a definite cause: many people with a recognised risk factor never develop the disease, and some people develop it without an obvious risk factor. A clinician may ask about family history, medicines, previous illnesses, environmental exposures and other autoimmune symptoms to understand the broader context.
Assessment for ankylosing spondylitis may include clinical assessment of the back, hips, posture, chest expansion and peripheral joints; inflammatory markers such as CRP and ESR; HLA-B27 when appropriate; pelvic X-rays; and MRI of the sacroiliac joints when early inflammation is suspected. Diagnosis relies on the whole clinical picture, not one test. The exact investigations depend on the symptoms and organs that may be involved. Not every person needs every test. Results must be interpreted alongside the clinical examination, because isolated abnormalities can occur for reasons unrelated to the suspected disease.
Treatment for ankylosing spondylitis is individualised. Depending on the diagnosis and severity, approaches may include education, regular exercise and physiotherapy are central. NSAIDs may be considered after reviewing kidney, stomach and cardiovascular risks. If active disease persists, a specialist may consider biologic medicines such as TNF or IL-17 inhibitors, or selected targeted synthetic medicines. Treatment choice considers associated psoriasis, uveitis and inflammatory bowel disease. The goal may be to reduce inflammation, control symptoms, prevent organ damage, preserve function or manage complications. Not every treatment is suitable for every patient, and some medicines require blood tests, infection screening or other safety checks before and during use.
Supportive measures for people living with ankylosing spondylitis may include regular spinal mobility and posture exercises, strengthening, walking, swimming or other suitable aerobic activity, not smoking, adequate sleep and a balanced diet. Exercise should be adapted during flares and after injuries. People with significant spinal stiffness should discuss safe activity and fracture prevention with their clinician. These measures complement, rather than replace, medical treatment when treatment is indicated. The right level of activity, dietary changes and monitoring will depend on the person's health and the organs involved.
Potential complications of ankylosing spondylitis include uveitis, hip arthritis, reduced spinal mobility, osteoporosis and vertebral fracture risk. Some people have associated inflammatory bowel disease, psoriasis or cardiovascular risk. Sudden painful red eye, light sensitivity or blurred vision needs urgent eye assessment. Complications are not inevitable, and their likelihood depends on the disease subtype, duration, activity, co-existing conditions and response to treatment. Monitoring is intended to identify changes early and to balance disease control against possible medicine-related effects.
Medical evaluation is appropriate for persistent back pain beginning before age 45 and lasting more than three months, especially when it improves with movement or is associated with night pain, buttock pain, heel pain, psoriasis or a family history. New neurological symptoms or severe pain after even minor trauma need urgent assessment. Anyone with a known diagnosis should follow the monitoring schedule advised by their clinician, even when symptoms are stable. New symptoms should be discussed rather than assumed to be part of the existing condition. Severe or rapidly worsening symptoms may require urgent or emergency assessment.
Ankylosing Spondylitis can affect people in different ways, so assessment and management need to be tailored to the individual. Understanding the symptoms, diagnostic process, treatment choices and possible complications can help patients take part in informed discussions about their care. Regular follow-up, appropriate investigations and a plan that reflects disease activity are important parts of long-term management. The information in this article is general and should be discussed with a qualified healthcare professional in the context of an individual's circumstances.
What is ankylosing spondylitis?
Ankylosing spondylitis is a chronic inflammatory condition within the axial spondyloarthritis group. It mainly affects the sacroiliac joints and spine, causing inflammatory back pain and stiffness. Some people also develop inflammation in the hips, shoulders, heels, eyes, skin or bowel. The course varies, and not everyone develops spinal fusion. The exact features and severity vary, so assessment is based on the individual's clinical history, examination and relevant investigations.
What are common symptoms?
Symptoms may include gradual-onset lower-back or buttock pain; stiffness after rest or on waking; pain that may improve with movement; waking during the second half of the night because of back discomfort; reduced spinal flexibility; heel pain; fatigue; or episodes of a painful red eye. Symptoms commonly begin before age 45 but can vary. Similar features can occur in other conditions, so persistent or unexplained symptoms should be medically assessed.
How is the condition diagnosed?
Assessment may include clinical assessment of the back, hips, posture, chest expansion and peripheral joints; inflammatory markers such as CRP and ESR; HLA-B27 when appropriate; pelvic X-rays; and MRI of the sacroiliac joints when early inflammation is suspected. Diagnosis relies on the whole clinical picture, not one test. No single result should generally be interpreted in isolation; the findings are considered alongside symptoms and examination.
What treatments may be used?
Depending on severity and the organs involved, treatment may include education, regular exercise and physiotherapy are central. NSAIDs may be considered after reviewing kidney, stomach and cardiovascular risks. If active disease persists, a specialist may consider biologic medicines such as TNF or IL-17 inhibitors, or selected targeted synthetic medicines. Treatment choice considers associated psoriasis, uveitis and inflammatory bowel disease. The appropriate plan is individualised and requires medical supervision.
Can lifestyle changes replace medical treatment?
Lifestyle measures may support general health and symptom management, but they do not replace prescribed treatment when a clinician considers disease-modifying or organ-protective therapy necessary.
When should someone seek urgent medical care?
Seek prompt assessment for persistent back pain beginning before age 45 and lasting more than three months, especially when it improves with movement or is associated with night pain, buttock pain, heel pain, psoriasis or a family history. New neurological symptoms or severe pain after even minor trauma need urgent assessment. If symptoms are severe, sudden or rapidly worsening, use local emergency services.
Medical and editorial note: This is general educational information, not personal medical advice. A qualified clinician should review the medical accuracy, local applicability and final wording before publication. Do not add unverified credentials, superiority claims, patient testimonials, guaranteed outcomes, discounts or inducements.
NMC content note: The NMC Public Notice No. R-13014/01/2024-Ethics dated 6 October 2026 addresses ethical advertising and public communication by registered medical practitioners and medical institutions. Educational material should remain factual, balanced and non-misleading; whether a particular website page is treated as advertising depends on its content, context and use.